John A. Glaspy - Publications, H-index & Citations

Back

John A. Glaspy

UCLA

89H-index

720Paper Count

3.8WCitation Count

Published Papers 109

Publication Date

Oncofertility patterns after the overturn of Roe v. Wade

JNCI: Journal of the National Cancer Institute

IF0

2026-04-18

OAAI

Nikita V Baclig, MD, MPH; Jordyn Silverstein, MD; Vrushangi Shah; Beth Karlan, MD; Sidharth R Anand, MD, MBA; John A Glaspy, MD; null

Save

Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial

Communications Medicine

IF6.3

2026-02-06

OAAI

Blair V. Landon; Julia L. Boland; Andrea E. Wahner Hendrickson; Deborah K. Armstrong; Boris Winterhoff; Jaime Wehr; Akshaya V. Annapragada; Christopher Cherry; Archana Balan; Guneet Kaleka; Victor E. Velculescu; Stephen B. Baylin; Cynthia A. Zahnow; Dennis J. Slamon; Gottfried E. Konecny; Valsamo Anagnostou; John A. Glaspy

Save

A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies

ESMO OPEN

IF8.3

2024-08-01

OAAI

Curigliano, G.; Jimenez, M. M.; Shimizu, T.; Keam, B.; Meric-Bernstam, F.; Rutten, A.; Glaspy, J.; Schuler, P. J.; Parikh, N. S.; Ising, M.; Hassounah, N.; Wu, J.; Leyk, M.; Chen, X.; Burks, H.; Chaudhury, A.; Otero, J.; Cabanas, E. Garralda

Save

Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2024-06-17

OAAI

Mittelman, Moshe; Henry, David H.; Glaspy, John A.; Tombak, Anil; Harrup, Rosemary; Kim, Inho; Madry, Krzysztof; Grabowska, Barbara; Lee, Tyson; Modelska, Katharina

Save

Combined epigenetic therapy and immune checkpoint blockade drive reshaping of the tumor microenvironment of platinum resistant ovarian cancer

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Landon, Blair V.; Kaleka, Guneet; Balan, Archana; Boland, Julia L.; Cherry, Christopher; Pereira, Gavin; Zahnow, Cynthia; Winterhoff, Boris; Baylin, Stephen; Velculescu, Victor E.; Konecny, Gottfried E.; Glaspy, John A.; Anagnostou, Valsamo

Save

TORL-3-600, a novel antibody drug conjugate directed against cadherin 17 (CDH17), has preclinical efficacy in colorectal, gastric, and pancreatic cancer

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

O'Brien, Neil A.; McDermott, Martina S. J.; Zhang, Jun; Lu, Ming; Gong, Ke Wei; Hoffstrom, Benjamin; Jia, Wei Ping; Luo, Tong; Madrid, Athena M.; Liang, Min; Glaspy, John A.; Slamon, Dennis J.

Save

Therapeutic potential of TORL-4-500, an antibody-drug conjugate directed against delta like non-canonical notch ligand 1 (DLK1)

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

McDermott, Martina S.; O'Brien, Neil A.; Lu, Ming; Zhang, Jun; Gong, KeWei; Hoffstrom, Benjamin; Luo, Tong; Liang, Min; Jia, Weiping; Chau, Kevin; Presta, Leonard; Glaspy, John; Slamon, Dennis J.

Save

Exploring the unexplored: Clinical trial investigator perspectives of disparities in racial/ethnic minority participation in oncology clinical trials

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2023-12-01

PREAI

Bransky, Natalie P.; Walling, Anne M.; Glaspy, John A.; Garcia-Jimenez, Maria

Save

Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody-Drug Conjugate for Treatment of CLDN18.2-Positive Cancers

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-10-03

PREAI

O'Brien, Neil A.; McDermott, Martina S. J.; Zhang, Jun; Gong, Ke Wei; Lu, Ming; Hoffstrom, Benjamin; Luo, Tong; Ayala, Raul; Chau, Kevin; Liang, Min; Madrid, Athena M.; Donahue, Timothy R.; Glaspy, John A.; Presta, Leonard; Slamon, Dennis J.

Save

Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2023-09-01

PREAI

Wu, Trudy C.; Stube, Annalise; Felix, Carol; Oseguera, Denise; Romero, Tahmineh; Goldman, Jonathan; Garon, Edward B.; Lee, Jay M.; Glaspy, John; Lisberg, Aaron E.; Rusthoven, Chad G.; Camidge, D. Ross; Siva, Shankar; Solomon, Benjamin; Lee, Alan; Tenn, Stephen E.; Shaverdian, Narek; Steinberg, Michael L.; Raldow, Ann C.; Lee, Percy

Save

Development of UCT-01-097, a novel orally available ERK1/2 inhibitor for the treatment of ERK1/2 dependent cancers

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

O'Brien, Neil A.; McDermott, Martina S.; O'Boyle, Brendan M.; Reeves, Corey M.; Bartberger, Michael; Loson, Oliver; Chau, Kevin; Hong, Jenny J.; Jia, Weiping; Kamranpour, Naeimeh; Luo, Tong; Ayala, Raul; Madrid, Athena M.; Glaspy, John A.; Stoltz, Brian M.; Slamon, Dennis J.

Save

Development and characterization of a novel CDK4/6 inhibitor for the treatment of CDK4/6 dependent cancers

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

O'Brien, Neil A.; McDermott, Martina S.; O'Boyle, Brendan M.; Hilf, Justin A.; Loson, Oliver; Chau, Kevin; Jia, Weiping; Kamranpour, Naeimeh; Luo, Tong; Ayala, Raul; Issakhanian, Shawnt; Glaspy, John A.; Stoltz, Brian M.; Slamon, Dennis J.

Save

Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2023-02-24

OAAI

Glaspy, John; Gabrail, Nashat Y.; Locantore-Ford, Patricia; Lee, Tyson; Modelska, Katharina; Samal, Vivek; Henry, David H.

Save

Risks for Anaphylaxis With Intravenous Iron Formulations Comment

ANNALS OF INTERNAL MEDICINE

IF15.2

2022-11-01

PREAI

Al-Samkari, Hanny; Glaspy, John A.; Means, Robert T.; Chertow, Glenn M.; Auerbach, Michael

Save

Exceptional Response to Erdafitinib in FGFR2-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2022-10-01

OAAI

Ng, Camille F.; Glaspy, John; Placencio-Hickok, Veronica R.; Thomassian, Shant; Gong, Jun; Osipov, Arsen; Hendifar, Andrew E.; Moshayedi, Natalie

Save

Hematopoietic Growth Factors, Version 1.2022 Featured Updates to the NCCN Guidelines

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2022-05-01

OAAI

Griffiths, Elizabeth A.; Roy, Vivek; Alwan, Laura; Bachiashvili, Kimo; Baird, John; Cool, Rita; Dinner, Shira; Geyer, Mark; Glaspy, John; Gojo, Ivana; Hicks, Ashley; Kallam, Avyakta; Kidwai, Wajih Zaheer; Kloth, Dwight D.; Kraut, Eric H.; Landsburg, Daniel; Lyman, Gary H.; Mahajan, Anjlee; Miller, Ryan; Nachar, Victoria; Patel, Seema; Patel, Shiven; Perez, Lia E.; Poust, Adam; Riaz, Fauzia; Rosovsky, Rachel; Rugo, Hope S.; Simon, Shayna; Vasu, Sumithira; Wadleigh, Martha; Westbrook, Kelly; Westervelt, Peter; Berardi, Ryan A.; Pluchino, Lenora

Save

Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2021-11-09

OAAI

Henry, David H.; Glaspy, John; Harrup, Rosemary; Mittelman, Moshe; Zhou, Amy; Carraway, Hetty E.; Bradley, Charles; Saha, Gopal; Modelska, Katharina; Bartels, Pamela; Leong, Robert; Yu, Kin-Hung P.

Save

A careful reassessment of anthracycline use in curable breast cancer

NPJ BREAST CANCER

IF7.6

2021-10-08

OAAI

Hurvitz, Sara Alsterlind; McAndrew, Nicholas P.; Bardia, Aditya; Press, Michael F.; Pegram, Mark; Crown, John P.; Fasching, Peter A.; Ejlertsen, Bent; Yang, Eric H.; Glaspy, John A.; Slamon, Dennis J.

Save

Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis

CELL REPORTS MEDICINE

IF10.6

2021-10-01

OAAI

Ferrian, Selena; Liu, Candace C.; McCaffrey, Erin F.; Kumar, Rashmi; Nowicki, Theodore S.; Dawson, David W.; Baranski, Alex; Glaspy, John A.; Ribas, Antoni; Bendall, Sean C.; Angelo, Michael

Save

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

ADVANCES IN THERAPY

IF4

2021-05-30

OAAI

Glaspy, John A.; Wolf, Myles; Strauss, William E.

Save

Research Directions